Chemosphere. 2019 May;223:165-170. doi: 10.1016/j.chemosphere.2019.01.169. Epub 2019 Feb 1.
Polychlorinated diphenyl sulfides can induce ROS and genotoxicity via the AhR-CYP1A1 pathway.
Leuk Lymphoma. 2019 Mar;60(3):772-781. doi: 10.1080/10428194.2018.1493727. Epub 2019 Jan 15.
Targeting the cross-talk between the hedgehog and NF-κB signaling pathways in multiple myeloma.
Front Microbiol.2019 Apr 24;10:813. doi:10.3389/fmicb.2019.00813. eCollection 2019.
Protective Effect Against Toxoplasmosis in BALB/c Mice Vaccinated With Toxoplasma gondii Macrophage Migration Inhibitory Factor
J Cell Physiol. 2019 Apr;234(4):3720-3729.doi: 10.1002/jcp.27146. Epub 2018 Oct 14.
MiR-208b regulates cell cycle and promotes skeletal muscle cell proliferation by targeting CDKN1A
Free Radic Biol Med. 2019 Apr;134:23-41.doi: 10.1016/j.freeradbiomed.2018.12.034. Epub 2018 Dec 30.
Loss of RIP3 initiates annihilation of high-fat diet initialized nonalcoholic hepatosteatosis: A mechanism involving Toll-like receptor 4 and oxidative stress
BMB Rep.2019 Apr;52(4):277-282.doi: 10.5483/BMBRep.2019.52.4.263.
Insufficient radiofrequency ablation-induced autophagy contributes to the rapid progression of residual hepatocellular carcinoma through the HIF-1α/BNIP3 signaling pathway
Mol Cancer. 2019 Mar 30;18(1):61. doi: 10.1186/s12943-019-0978-2.
Long noncoding RNA Pvt1 regulates the immunosuppression activity of granulocytic myeloid-derived suppressor cells in tumor-bearing mice.
J Cell Biochem. 2019 Mar;120(3):2847-2858.doi: 10.1002/jcb.26567. Epub 2018 Nov 30.
Effects of microrna-93 on mouse cardiac microvascular endothelial cells injury and inflammatory response by mediating SPP1 through the NF-ΚB pathway
Dev Comp Immunol. 2019 Mar;92:150-159.doi: 10.1016/j.dci.2018.11.006. Epub 2018 Nov 11.
Global profiling of megalocytivirus-induced proteins in tongue sole (Cynoglossus semilaevis) spleen identifies cellular processes essential to viral infection
J Cell Biochem. 2019 Mar;120(3):2973-2982.doi: 10.1002/jcb.27025. Epub 2018 Dec 5.
miR-202 modulates the progression of neuropathic pain through targeting RAP1A
